26 related articles for article (PubMed ID: 38727853)
1. Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
Tanaka R; Ueki Y; Ohshima S; Omata J; Yokoyama Y; Takahashi T; Shodo R; Yamazaki K; Ohtaki K; Togashi T; Horii A
Int J Clin Oncol; 2024 May; ():. PubMed ID: 38727853
[TBL] [Abstract][Full Text] [Related]
2. Oncologic and functional outcomes of neoadjuvant chemotherapy followed by surgery in human papillomavirus-positive tonsillar cancer.
Bang J; Shin HI; Kim GJ; Kim SY; Sun DI
Head Neck; 2023 Oct; 45(10):2580-2588. PubMed ID: 37587905
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck Cancer.
Sun L; Candelieri-Surette D; Anglin-Foote T; Lynch JA; Maxwell KN; D'Avella C; Singh A; Aakhus E; Cohen RB; Brody RM
JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1022-1028. PubMed ID: 36136306
[TBL] [Abstract][Full Text] [Related]
4. Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer.
Chaukar D; Prabash K; Rane P; Patil VM; Thiagarajan S; Ghosh-Laskar S; Sharma S; Pai PS; Chaturvedi P; Pantvaidya G; Deshmukh A; Nair D; Nair S; Vaish R; Noronha V; Patil A; Arya S; D'Cruz A
J Clin Oncol; 2022 Jan; 40(3):272-281. PubMed ID: 34871101
[TBL] [Abstract][Full Text] [Related]
5. Determinants of delay and association with outcome in head and neck cancer: A systematic review.
Schoonbeek RC; Zwertbroek J; Plaat BEC; Takes RP; Ridge JA; Strojan P; Ferlito A; van Dijk BAC; Halmos GB
Eur J Surg Oncol; 2021 Aug; 47(8):1816-1827. PubMed ID: 33715909
[TBL] [Abstract][Full Text] [Related]
6. Time to Surgery and Survival in Head and Neck Cancer.
Rygalski CJ; Zhao S; Eskander A; Zhan KY; Mroz EA; Brock G; Silverman DA; Blakaj D; Bonomi MR; Carrau RL; Old MO; Rocco JW; Seim NB; Puram SV; Kang SY
Ann Surg Oncol; 2021 Feb; 28(2):877-885. PubMed ID: 33188461
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil.
Shirasu H; Yokota T; Kawakami T; Hamauchi S; Onozawa Y; Ogawa H; Onoe T; Mori K; Onitsuka T
Int J Clin Oncol; 2020 Nov; 25(11):1914-1920. PubMed ID: 32648132
[TBL] [Abstract][Full Text] [Related]
8. Changes in head and neck oncologic practice during the COVID-19 pandemic.
Brody RM; Albergotti WG; Shimunov D; Nicolli E; Patel UA; Harris BN; Bur AM
Head Neck; 2020 Jul; 42(7):1448-1453. PubMed ID: 32357380
[TBL] [Abstract][Full Text] [Related]
9. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Enokida T; Ogawa T; Homma A; Okami K; Minami S; Nakanome A; Shimizu Y; Maki D; Ueda Y; Fujisawa T; Motegi A; Ohkoshi A; Taguchi J; Ebisumoto K; Nomura S; Okano S; Tahara M
Cancer Med; 2020 Mar; 9(5):1671-1682. PubMed ID: 31943834
[TBL] [Abstract][Full Text] [Related]
10. Association of Delayed Time to Treatment Initiation With Overall Survival and Recurrence Among Patients With Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population.
Liao DZ; Schlecht NF; Rosenblatt G; Kinkhabwala CM; Leonard JA; Ference RS; Prystowsky MB; Ow TJ; Schiff BA; Smith RV; Mehta V
JAMA Otolaryngol Head Neck Surg; 2019 Nov; 145(11):1001-1009. PubMed ID: 31513264
[TBL] [Abstract][Full Text] [Related]
11. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.
Haddad RI; Massarelli E; Lee JJ; Lin HY; Hutcheson K; Lewis J; Garden AS; Blumenschein GR; William WN; Pharaon RR; Tishler RB; Glisson BS; Pickering C; Gold KA; Johnson FM; Rabinowits G; Ginsberg LE; Williams MD; Myers J; Kies MS; Papadimitrakopoulou V
Ann Oncol; 2019 Mar; 30(3):471-477. PubMed ID: 30596812
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).
Tahara M; Kiyota N; Yokota T; Hasegawa Y; Muro K; Takahashi S; Onoe T; Homma A; Taguchi J; Suzuki M; Minato K; Yane K; Ueda S; Hara H; Saijo K; Yamanaka T
Ann Oncol; 2018 Apr; 29(4):1004-1009. PubMed ID: 29408977
[TBL] [Abstract][Full Text] [Related]
13. Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
Xiao R; Ward MC; Yang K; Adelstein DJ; Koyfman SA; Prendes BL; Burkey BB
Cancer; 2018 Apr; 124(7):1400-1414. PubMed ID: 29315499
[TBL] [Abstract][Full Text] [Related]
14. Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209.
Kitamura H; Tsukamoto T; Shibata T; Masumori N; Fujimoto H; Hirao Y; Fujimoto K; Kitamura Y; Tomita Y; Tobisu K; Niwakawa M; Naito S; Eto M; Kakehi Y;
Ann Oncol; 2014 Jun; 25(6):1192-8. PubMed ID: 24669010
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the freely available easy-to-use software 'EZR' for medical statistics.
Kanda Y
Bone Marrow Transplant; 2013 Mar; 48(3):452-8. PubMed ID: 23208313
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
Zhong LP; Zhang CP; Ren GX; Guo W; William WN; Sun J; Zhu HG; Tu WY; Li J; Cai YL; Wang LZ; Fan XD; Wang ZH; Hu YJ; Ji T; Yang WJ; Ye WM; Li J; He Y; Wang YA; Xu LQ; Wang BS; Kies MS; Lee JJ; Myers JN; Zhang ZY
J Clin Oncol; 2013 Feb; 31(6):744-51. PubMed ID: 23129742
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).
Ando N; Kato H; Igaki H; Shinoda M; Ozawa S; Shimizu H; Nakamura T; Yabusaki H; Aoyama N; Kurita A; Ikeda K; Kanda T; Tsujinaka T; Nakamura K; Fukuda H
Ann Surg Oncol; 2012 Jan; 19(1):68-74. PubMed ID: 21879261
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.
Kies MS; Holsinger FC; Lee JJ; William WN; Glisson BS; Lin HY; Lewin JS; Ginsberg LE; Gillaspy KA; Massarelli E; Byers L; Lippman SM; Hong WK; El-Naggar AK; Garden AS; Papadimitrakopoulou V
J Clin Oncol; 2010 Jan; 28(1):8-14. PubMed ID: 19917840
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
